This is a snippet of the transcript, sign up to read more.
The perception of the banking industry has turned negative, with bankers often seen as the "bad guys" in these scenarios. This has led to numerous regulatory fines for many institutions, causing banks to tighten their risk appetite. As banks are punished for engaging in potentially risky work, they become less likely to take on such tasks, narrowing their focus. This has had a domino effect on other areas of the industry, leading to unintended consequences, which could potentially segue into our conversation on Alpha.
This is a snippet of the transcript, sign up to read more.
The main selling point that led to us doing business with them was their work with Luxembourg funds and illiquid alternative funds. When setting up these funds, you need a GP, which is a corporate entity, and a partnership, typically an SCSP in Luxembourg. To establish a GP in Luxembourg, you need a notary and a bank account in existence before notarization. This requirement is unique to Luxembourg, as it is not needed in places like Jersey or the UK.
This is a snippet of the transcript, sign up to read more.
Luxembourg's partnership law is more recognizable to UK and US clients compared to Ireland. Therefore, it became crucial for fund managers to open bank accounts quickly and establish their entities. Traditional banks, however, were becoming less interested in providing basic banking services, as they were not significant revenue generators. Instead, they preferred to offer ancillary services like depository services, FX services, fund finance, and credit line finance. If it's just bank accounts, they are not interested. If it is just bank accounts for a fund manager they haven't heard of, they've got almost zero interest. Additionally, it was challenging for banks to retain employees in onboarding roles, leading to a slow and cumbersome onboarding process. Clients were becoming frustrated with the lengthy waiting times - maybe two or three months - to open bank accounts.
This is a snippet of the transcript, sign up to read more.
This document may not be reproduced, distributed, or transmitted in any form or by any means including resale of any part, unauthorised distribution to a third party or other electronic methods, without the prior written permission of IP 1 Ltd.
IP 1 Ltd, trading as In Practise (herein referred to as "IP") is a company registered in England and Wales and is not a registered investment advisor or broker-dealer, and is not licensed nor qualified to provide investment advice.
In Practise reserves all copyright, intellectual and other property rights in the Content. The information published in this transcript (“Content”) is for information purposes only and should not be used as the sole basis for making any investment decision. Information provided by IP is to be used as an educational tool and nothing in this Content shall be construed as an offer, recommendation or solicitation regarding any financial product, service or management of investments or securities. The views of the executive expressed in the Content are those of the expert and they are not endorsed by, nor do they represent the opinion of In Practise. In Practise makes no representations and accepts no liability for the Content or for any errors, omissions, or inaccuracies will in no way be held liable for any potential or actual violations of laws, including without limitation any securities laws, based on Information sent to you by In Practise.
© 2024 IP 1 Ltd. All rights reserved.
Subscribe to access hundreds of interviews and primary research